Cervical cancer vaccine cleared for Chinese clinics

The first imported batch of Cervarix, the cervical cancer vaccine, has passed quality inspections and is heading to health clinics across the Chinese mainland, pharmaceutical company GlaxoSmithKline said on Monday.